Graham, Shirley <br/><br/>
Potent, synergistic inhibition of Staphylococcus aureus upon exposure to a combination of the endopeptidase lysostaphin and the cationic peptide ranalexin.  [electronic resource] 

 -  The Journal of antimicrobial chemotherapy  Apr 2007 
 - 759-62 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0305-7453 
<br/><br/><label>Standard No.: </label>10.1093/jac/dkl539  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anti-Bacterial Agents--pharmacology<br/>Bacteria--drug effects<br/>Drug Synergism<br/>Lysostaphin--pharmacology<br/>Microbial Sensitivity Tests<br/>Peptides, Cyclic--pharmacology<br/>Staphylococcus aureus--drug effects